THY1 and nephritis: Previous studies have shown that many antiproliferative therapies such as PDGF antagonists, heparin, mycophenolate mofetil and the cell cycle inhibitors provide renal protection in the anti-Thy1-induced nephritis [9,20,21,22,23].